FULC
Fulcrum Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.74 / 10
Netural
Fulcrum's financial health is moderate with several positives: a strong inventory turnover ratio (47.88) and interest-coverage ratio (15.51), alongside robust YoY revenue growth (Total: 78.62%, Operating: 92.79%). However, a high PB-ROE reading (1.26) and sub-par asset-to-market value (-0.51) temper the outlook. Net profit represents 100% of total profit, signaling clean earnings, but the mixed factor scores result in an overall neutral fundamental rating.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight22.26%
1M Return11.03%
Value-0.26
Score3/3
Weight22.26%
1M Return11.03%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.85%
1M Return-1.23%
Value47.88
Score2/3
Weight-1.85%
1M Return-1.23%
PB-ROE
Value1.26
Score1/3
Weight18.07%
1M Return8.79%
Value1.26
Score1/3
Weight18.07%
1M Return8.79%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.16%
1M Return0.10%
Value92.79
Score2/3
Weight0.16%
1M Return0.10%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.52%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.52%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.43%
1M Return0.88%
Value78.62
Score3/3
Weight1.43%
1M Return0.88%
Profit-MV
Value0.47
Score2/3
Weight17.87%
1M Return8.99%
Value0.47
Score2/3
Weight17.87%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.93%
1M Return-1.25%
Value15.51
Score2/3
Weight-1.93%
1M Return-1.25%
Asset-MV
Value-0.51
Score3/3
Weight28.35%
1M Return11.94%
Value-0.51
Score3/3
Weight28.35%
1M Return11.94%
Cash-MV
Value-0.07
Score2/3
Weight17.15%
1M Return8.80%
Value-0.07
Score2/3
Weight17.15%
1M Return8.80%
Revenue-MV
Value-0.26
Score3/3
Weight22.26%
1M Return11.03%
Value-0.26
Score3/3
Weight22.26%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.43%
1M Return0.88%
Value78.62
Score3/3
Weight1.43%
1M Return0.88%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.85%
1M Return-1.23%
Value47.88
Score2/3
Weight-1.85%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight17.87%
1M Return8.99%
Value0.47
Score2/3
Weight17.87%
1M Return8.99%
PB-ROE
Value1.26
Score1/3
Weight18.07%
1M Return8.79%
Value1.26
Score1/3
Weight18.07%
1M Return8.79%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.93%
1M Return-1.25%
Value15.51
Score2/3
Weight-1.93%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.16%
1M Return0.10%
Value92.79
Score2/3
Weight0.16%
1M Return0.10%
Asset-MV
Value-0.51
Score3/3
Weight28.35%
1M Return11.94%
Value-0.51
Score3/3
Weight28.35%
1M Return11.94%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.52%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.52%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight17.15%
1M Return8.80%
Value-0.07
Score2/3
Weight17.15%
1M Return8.80%
Is FULC undervalued or overvalued?
- FULC scores 4.74/10 on fundamentals and holds a Fair valuation at present. Backed by its -24.71% ROE, 0.00% net margin, -7.41 P/E ratio, 2.66 P/B ratio, and -293.10% earnings growth, these metrics solidify its Netural investment rating.
